Cargando…

Combination of Novoseven and Feiba in Hemophiliac Patients with Inhibitors

The aim of this study is to investigate the effective therapeutic combination of recombinant VIIa(Novoseven) and factor eight inhibitor bypass activity(FEIBA) drugs for the bleedings of adult hemophiliac patients with inhibitors.19 bleeding episodes of 5 hemophilia A patients who were using bypassin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malkan, Umit Yavuz, Aksu, Salih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2018
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310920/ https://www.ncbi.nlm.nih.gov/pubmed/30613789 http://dx.doi.org/10.1515/med-2018-0090

Ejemplares similares

A Case of “Anaphylaxis” to NovoSeven in a Hemophiliac Patient
por: Wang, Andy, et al.
Publicado: (2023)

Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study
por: Ettingshausen, Carmen Escuriola, et al.
Publicado: (2023)

Management of Acquired Factor VIII Inhibitors With NovoSeven and Obizur
por: Miatech, Jennifer L, et al.
Publicado: (2021)

Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
por: Tjønnfjord, Geir E, et al.
Publicado: (2007)

The Factors Affecting Early Death in Newly Diagnosed APL Patients
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors
por: Antunes, S V, et al.
Publicado: (2014)

Fixed-Dose Factor Eight Inhibitor Bypassing Activity (FEIBA) in the Management of Warfarin-Associated Coagulopathies
por: Ibarra, Francisco, et al.
Publicado: (2022)

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
por: Turk, Seyhan, et al.
Publicado: (2017)

Indications and Outcomes of Splenectomy for Hematological Disorders
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
por: Wójcik, Cezary, et al.
Publicado: (2009)

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Low Bone Mineral Density in Hemophiliacs
por: Gebetsberger, Jennifer, et al.
Publicado: (2022)

Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven(®))
por: Viuff, D., et al.
Publicado: (2008)

Use of NovoSeven(® )in cases with massive bleeding following surgery with extracorporeal circulation
por: Dementieva, I, et al.
Publicado: (2004)

Ultrasound Evaluation of Tendinopathy in Hemophiliac Patients for the Purpose of Rehabilitation Indications
por: Donati, Danilo, et al.
Publicado: (2023)

Experience of NovoSeven administration in the management of severe haemorrhage following cardiac surgery of nonhaemophilic patients
por: Michalska, G, et al.
Publicado: (2007)

Antineoplastic Effects of Ankaferd Hemostat
por: Malkan, Umit Yavuz, et al.
Publicado: (2022)

Factor VIII haplotypes frequencies in Tunisian hemophiliacs A
por: Elmahmoudi, Hejer, et al.
Publicado: (2011)

Spontaneous intracerebral hemorrhage in hemophiliacs—A treatment dilemma
por: Hegde, Ajay, et al.
Publicado: (2016)

Spontaneous spinal epidural hematoma in a pediatric hemophiliac
por: Scalia, Gianluca, et al.
Publicado: (2023)

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
por: OKAY, Müfide, et al.
Publicado: (2019)

Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
por: AlGahtani, Farjah H., et al.
Publicado: (2010)

Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial
por: Sera, Valerie A., et al.
Publicado: (2021)

Surgical Risk on Patients with Coagulopathies: Guidelines on Hemophiliac Patients for Oro-Maxillofacial Surgery
por: Laino, Luigi, et al.
Publicado: (2019)

Case report: Acute cubital tunnel syndrome in a hemophiliac patient
por: Debkowska, Monika P, et al.
Publicado: (2019)

Inhibition of tissue factor pathway inhibitor (TFPI) by ARC19499 improves clotting of hemophiliac blood
por: Gorczyca, Monika E, et al.
Publicado: (2010)

Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Prevalence, Incidence, and Factor Concentrate Usage Trends of Hemophiliacs in Taiwan
por: Tu, Tsu-Chiang, et al.
Publicado: (2013)

Ultrasound-targeted hepatic delivery of factor IX in hemophiliac mice
por: Anderson, C D, et al.
Publicado: (2016)

Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock
por: Sobieszczyk, S, et al.
Publicado: (2003)

Experience of NovoSeven administration in management of coagulopathic bleedings after surgical interventions with extracorporeal circulation
por: Dzybinskaya, E, et al.
Publicado: (2006)

Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran
por: Golestani, Mina, et al.
Publicado: (2016)

Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: ALADAĞ, Elifcan, et al.
Publicado: (2021)

Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient
por: Moreno, Pilar, et al.
Publicado: (2009)

Conditional autoencoder pre-training and optimization algorithms for personalized care of hemophiliac patients
por: Buche, Cédric, et al.
Publicado: (2023)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission
por: Aydın, Mürüvvet Seda, et al.
Publicado: (2017)

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia
por: Ghasemi, Mehdi, et al.
Publicado: (2019)

A rare case of DIC in a patient with Wilson’s disease: D-penicillamine
por: Emre Parlar, Yavuz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iuii295t3t5idr4ifso3iubppv